"TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)". Muthukrishnan L. Oral Oncol 2022;134:106118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Muthukrishnan L. "TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)". Oral Oncol 2022;134:106118.
PMID: 36096048